Suppression of the ERK-SRF axis facilitates somatic cell reprogramming.

Area of Science:

• Cell Biology
• Stem Cell Research
• Molecular Biology

Background:

• The precise molecular mechanisms initiating somatic cell reprogramming into induced pluripotent stem cells (iPSCs) remain incompletely understood.
• Identifying key signaling pathways and molecular events is crucial for improving reprogramming efficiency and understanding pluripotency.
• Current methods often lack detailed insights into early-stage regulatory networks.

Purpose of the Study:

• To elucidate the molecular mechanisms governing the initiation of somatic cell reprogramming into iPSCs.
• To identify key signaling pathways and transcription factors that drive or inhibit the reprogramming process.
• To establish a high-efficiency reprogramming system for detailed mechanistic studies.

Main Methods:

• Generation of single-cell-derived clones using drug-inducible vectors encoding Oct4, Sox2, Klf4, and Myc.
• Implementation of a single-cell expansion strategy coupled with metabolic and epigenetic remodeling.
• Functional analyses including assessment of signaling pathway activity (ERK, SRF) and gene expression profiling.

Main Results:

• A high reprogramming efficiency was achieved through metabolic and epigenetic remodeling.
• Extracellular signal-regulated kinase (ERK) signaling was downregulated early in reprogramming, acting as a key driver of iPSC formation.
• Myc predominantly induced ERK suppression, which in turn upregulated iPSC conversion by suppressing serum response factor (SRF).
• SRF activation was found to inhibit reprogramming and pluripotency by upregulating immediate early genes.

Conclusions:

• Suppression of the ERK-SRF signaling axis represents an initial, critical molecular event facilitating iPSC formation.
• Myc plays a significant role in initiating reprogramming by downregulating ERK signaling.
• The ERK-SRF axis and its regulation by Myc offer potential surrogate markers for monitoring cellular reprogramming efficiency.